Steering Committee members
The Working Group consists of 8–10 experts in paediatric lipid disorders from across Europe and beyond. Members serve three-year terms, renewable once, with roles including Chair, Co-Chair, committee members, and an EAS representative. Meetings are held twice virtually and once in person annually. Members are nominated by the WG and approved by the EAS Executive Committee, ensuring diverse representation.
Current members
Chair 2025- 2028
UK
Co-chair 2025-2028
Norway
Co-chair 2025-2028
the Netherlands
Honorary Committee Member
the Netherlands
Committee Member 2025- 2028
Portugal
Committee Member 2025-2028
Slovenia
Committee Member 2026-2028
Czech Republic
Committee Member 2025- 2028
UK
Committee Member 2025- 2028
UK
Adjunct members 2026-2028
the Netherlands
Turkey
United States of America
Australia
Remit
The Paediatric Lipid Working Group (WG), reporting to the EAS Executive Committee, aims to advance scientific knowledge, clinical care, and awareness of inherited paediatric lipid disorders. It:
- Organises the annual Paediatric FH workshop
- Supports sessions on paediatric dyslipidaemias during the EAS congress
- Promotes early detection and awareness
- Encourages cross-regional collaboration
- Advises the EAS Executive Committee on paediatric FH diagnosis and management
Appointment of Working Group Members
Members are selected based on scientific or clinical expertise in paediatric lipidology. The WG reviews nominations and applications, promoting a balanced geographic and professional membership. Initial appointments were made by the existing group with EAS approval. Future members are nominated internally, with final approval from the WG and EAS Executive Committee. Terms last three years, with the possibility of renewal.